Growth of Value-Based Purchasing and Contracting for Cell & Gene Therapies Part 2

Improving Access and Affordability Without Bankrupting the Health Plan

As research and development of these cutting-edge therapies rapidly progress, employers have an opportunity to explore and implement cost-effective approaches for making these therapies available to employees and covered dependents who need them. Strategies include paying over time, negotiating rebates based on the therapy’s effectiveness and buying stop-loss insurance.

Read the full article on page 4 here: April 2025 The Self-Insurer by The Self-Insurer Magazine